Janus Henderson Group Plc - Dec 31, 2024 SCHEDULE 13G/A Report for 4D Molecular Therapeutics, Inc. Common Stock (FDMT)

Filing Manager: JANUS HENDERSON GROUP PLC
Reporting Manager: JANUS HENDERSON GROUP PLC
Security: 4D Molecular Therapeutics, Inc. Common Stock
Symbol: FDMT
Shares outstanding: 46M shares
Disclosed Ownership: 2.25M shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 11:34 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JANUS HENDERSON GROUP PLC	4.9%	2.25M	0	2.25M	Kristin Mariani	Head of North America Compliance, CCO